Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership.more
Bull Of The Day: Mylan, Inc. (MYL)
Mylan, Inc. (NYSE:MYL) is one of the leading players in the US generics market. The company holds immense potential as many blockbuster drugs have begun to go off-patent and many more will lose patent exclusivity in the next few years. Moreover, we aremore
European industry bodies voice concern over CoE's anti-counterfeiting system
Extract not available.more
US Capitol Capsule: Obama seeks to secure global supply chain; reveals new plan
Extract not available.more
Momenta drops 21% as US court permits at-risk launch of Amphastar/Watson generic Lovenox
Extract not available.more
Halaven beats 12-month reimbursement process in Italy with Eisai 's risk sharing deal
Extract not available.more
The return of the preclinical IPO? Cancer stem cell firm Verastem raises $55M
Extract not available.more
Infinity minus one: shares plummet as spiky saridegib fails in pancreatic cancer
Extract not available.more
Merck Gives Grant to Sarcoma Alliance to Update Peer-to-Peer Network
Merck has awarded $15,000 to the Sarcoma Alliance for its Peer-to-Peer Network, the national nonprofit announced today. ?Thank God the Sarcoma Alliance has this program,? says Sarah of St. Cloud, Fla. She and Brenda were matched five years ago.more
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and Globalmore
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
LONDON -- (Marketwire) -- 01/30/12 -- Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivanmore
GlaxoSmithKline is seeking an acquisition in Turkey-
GlaxoSmithKline Plc (GSK), the U.K.s largest drugmaker, is seeking an acquisition in as it struggles to become profitable in the country, Hurriyet said, citing the companys emerging markets president.Potential targets include producers of cardiovascularmore
Merck Gives Grant to Sarcoma Alliance to Update Peer-to-Peer Network
By Internet and phone, the national nonprofit organization connects people with a rare cancer called sarcoma. The grant will go for software and printing expenses. Sarah, who participates in the Sarcoma Alliance's Peer-to-Peer Network Merck has awardedmore
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and Globalmore
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility Merck Serono
LONDON -- (Marketwire) -- 01/30/12 -- Based on its recent analysis of the infertility therapeutics market, Frost & Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost & Sullivanmore
Apricus, PediatRx sign co-promotion agreement for Granisol and Aquoral
Apricus Biosciences and PediatRx have signed an agreement for US co-promotion of Granisol (granisetron) oral solution and Aquoral spray and purchase of non-US rights to Granisol. Under the term sheet for the co-promotion and sale agreement, Apricus willmore
FDA accepts NDA for Pfizer CML drug
The FDA has accepted Pfizer?s new drug application (NDA) for standard review of bosutinib for patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML). Bosutinib is an oral, once-daily, investigational dualmore
Infinity presents interim data of phase 2 study in metastatic pancreatic cancer
Infinity Pharmaceuticals has reported interim data from its double-blind, randomized, placebo-controlled Phase 2 study comparing saridegib (IPI-926) in combination with gemcitabine to placebo plus gemcitabine in patients with previously untreated,more
FDA clears Bydureon for Type 2 Diabetes
Amylin Pharmaceuticals and Alkermes have announced that the US Food and Drug Administration (FDA) has approved Bydureon (exenatide extended-release for injectable suspension) indicated for type 2 diabetes. Bydureon is a glucagon-like peptide-1 (GLP-1)more
Takeda Bio initiates Orteronel Phase III clinical trials in Japan
Takeda Pharmaceutical and Millennium, the Takeda Oncology Company have announced that Takeda Bio Development Center (Takeda Bio) has commenced patient enrollment for the two ongoing global Phase III clinical trials for the anti-prostate cancermore
Pinpoint Genomics releases Pinpoint Dx Lung Assay
Pinpoint Genomics has made available its Pinpoint Dx Lung Assay to clinicians and patients through the company's laboratory in California, US. The assay is a molecular diagnostic assay that differentiates between patients at high, intermediate or lowmore
TNT EXPRESS: launches PharmaSafe, the all-in-one transport solution for tempera..
The service will be presented tomorrow in Basel at Cool Chain Logistics Europe 2012 30 January 2012 - TNT Express launches PharmaSafe, a specialised temperature-controlled service for the reliable transport of large quantities of pharmaceutical products,more
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Europe Frost & Sullivan Award for Competitive Strategy Leadership. The European hormone products market for infertility has been relatively stagnant over a decade with less differentiation in terms of product characteristics and delivery mechanisms.more
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and Globalmore
Frost & Sullivan Honours Merck Serono for Its Achievements in the Treatment of Infertility
Merck Serono Receives the 2011 Europe Frost & Sullivan Award for Competitive Strategy Leadership in Recognition of the Success of Its Comprehensive Portfolio of Hormone-Based Therapeutic Products and Strategic Expansion Across European and Globalmore